Author

Georgia Hemingway

Observed name: G Hemingway

Observed institution: UK Health Security Agency

OpenAlex ID: A5066955321

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 369

Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-CoV-2 exposure

2022 · Catherine J. Reynolds, Corinna Pade, et al. · Science · 337

Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals

2023 · Ashley D. Otter, Scott Jones, et al. · Nature Communications · 51

Screening of wild deer populations for exposure to SARS‐CoV‐2 in the United Kingdom, 2020–2021

2022 · Maya Holding, Ashley David Otter, et al. · Transboundary and Emerging Diseases · 22

Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response

2022 · Ivan Doykov, Tomas Baldwin, et al. · Cell Reports Methods · 11

Analogous humoral antigen recognition between Monkeypox-infected and Smallpox-vaccinated individuals

2022 · Ashley D. Otter, Scott Jones, et al. · medRxiv · 8

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

Works count: 7

Citation count: 799

H-index: 6

I10-index: 5